Beta-adrenergic receptors in coronary and skeletal muscle arteries.
D000083:Acetanilides / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001158:Arteries; D001667:Binding, Competitive; D002395:Catecholamines / Q000494:pharmacology; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000098:blood supply*; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology; D013997:Time Factors
D000083:Acetanilides; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002395:Catecholamines; D011437:Propylamines; D011941:Receptors, Adrenergic; D013565:Sympatholytics; D010643:Phenoxybenzamine; D011189:Potassium Chloride; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine